Pfizer said it expects to deliver 200 million doses of its Covid-19 vaccine to the United States by the end of May, according to slides published for its fourth-quarter 2020 earnings teleconference on Tuesday.
The company was originally slated to deliver the 200 million doses by July 31, but Pfizer CEO Albert Bourla said last week he expected the company’s production to be ahead of schedule by two months.
“In the US, we had promised to provide 100 million doses by the end of the first quarter and we will be able to provide 120 right now,” Bourla said last week. “The same is with second quarter. We were planning to provide them all the way to 200 million doses by the end of the second quarter, actually beginning of the third. Right now, we will be able to provide the 200 million doses two months earlier.”
The Biden administration has also announced it will be purchasing an additional 100 million doses from the company.
As of Jan. 31, Pfizer says it has supplied 20 million doses to the US.
According to the US Centers for Disease Control, 17,364,398 doses of the Pfizer vaccine have been administered.